Origin Life Sciences, Inc. (OLSI)

Origin Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021
Cash & Equivalents	0.55	0
Cash & Cash Equivalents	0.55	0
Cash Growth	12197.67%	-
Other Current Assets	0.7	0.29
Total Current Assets	1.25	0.3
Long-Term Investments	0.17	0.21
Goodwill and Intangibles	0.25	0.45
Other Long-Term Assets	0.07	0.07
Total Long-Term Assets	0.49	0.72
Total Assets	1.74	1.02
Accounts Payable	1.27	1.39
Current Debt	0.06	0.11
Other Current Liabilities	9.72	7.86
Total Current Liabilities	11.05	9.35
Long-Term Debt	2.63	1.2
Other Long-Term Liabilities	4.92	4.38
Total Long-Term Liabilities	7.55	5.58
Total Liabilities	18.6	14.93
Total Debt	2.68	1.31
Debt Growth	105.30%	-
Retained Earnings	-86.32	-77.48
Comprehensive Income	-0.12	-0.09
Shareholders' Equity	-19.79	-16.85
Net Cash / Debt	-2.13	-1.3
Working Capital	-9.8	-9.06

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).